Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Oct 7, 2008; 14(37): 5738-5743
Published online Oct 7, 2008. doi: 10.3748/wjg.14.5738
Published online Oct 7, 2008. doi: 10.3748/wjg.14.5738
Table 2 Perfusion parameters in PD group (mean ± SD)
| PD (n = 10) | Pre-treatment | Post-treatment | P value |
| HBF (mL/min per 100 mL) | 178.508 ± 63.650 | 263.828 ± 91.731 | 0.005 |
| HBV (mL/100 mL) | 28.101 ± 26.862 | 29.978 ± 9.261 | 0.385 |
| MTT (S) | 9.336 ± 2.517 | 10.001 ± 2.457 | 0.798 |
| PS (mL/min/100 mL) | 33.103 ± 3.784 | 26.384 ± 10.544 | 0.092 |
| HAF (%) | 45.856 ± 41.332 | 69.628 ± 30.126 | 0.012 |
| HAP (mL/min per 100 mL) | 32.686 ± 7.145 | 94.200 ± 55.928 | 0.005 |
| PVP (mL/min per 100 mL) | 19.820 ± 5.546 | 33.480 ± 8.765 | 0.035 |
- Citation: Chen G, Ma DQ, He W, Zhang BF, Zhao LQ. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2008; 14(37): 5738-5743
- URL: https://www.wjgnet.com/1007-9327/full/v14/i37/5738.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.5738